315 related articles for article (PubMed ID: 18506748)
1. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.
Scotto L; Narayan G; Nandula SV; Arias-Pulido H; Subramaniyam S; Schneider A; Kaufmann AM; Wright JD; Pothuri B; Mansukhani M; Murty VV
Genes Chromosomes Cancer; 2008 Sep; 47(9):755-65. PubMed ID: 18506748
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.
Scotto L; Narayan G; Nandula SV; Subramaniyam S; Kaufmann AM; Wright JD; Pothuri B; Mansukhani M; Schneider A; Arias-Pulido H; Murty VV
Mol Cancer; 2008 Jun; 7():58. PubMed ID: 18559093
[TBL] [Abstract][Full Text] [Related]
3. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.
Narayan G; Murty VV
Future Oncol; 2010 Oct; 6(10):1643-52. PubMed ID: 21062161
[TBL] [Abstract][Full Text] [Related]
5. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
[TBL] [Abstract][Full Text] [Related]
6. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
7. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
Narayan G; Bourdon V; Chaganti S; Arias-Pulido H; Nandula SV; Rao PH; Gissmann L; Dürst M; Schneider A; Pothuri B; Mansukhani M; Basso K; Chaganti RS; Murty VV
Genes Chromosomes Cancer; 2007 Apr; 46(4):373-84. PubMed ID: 17243165
[TBL] [Abstract][Full Text] [Related]
8. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
[TBL] [Abstract][Full Text] [Related]
9. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract][Full Text] [Related]
10. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
Carvalho B; Postma C; Mongera S; Hopmans E; Diskin S; van de Wiel MA; van Criekinge W; Thas O; Matthäi A; Cuesta MA; Terhaar Sive Droste JS; Craanen M; Schröck E; Ylstra B; Meijer GA
Gut; 2009 Jan; 58(1):79-89. PubMed ID: 18829976
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.
Tabach Y; Kogan-Sakin I; Buganim Y; Solomon H; Goldfinger N; Hovland R; Ke XS; Oyan AM; Kalland KH; Rotter V; Domany E
PLoS One; 2011 Jan; 6(1):e14632. PubMed ID: 21297939
[TBL] [Abstract][Full Text] [Related]
12. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix.
Wilting SM; Snijders PJ; Meijer GA; Ylstra B; van den Ijssel PR; Snijders AM; Albertson DG; Coffa J; Schouten JP; van de Wiel MA; Meijer CJ; Steenbergen RD
J Pathol; 2006 Jun; 209(2):220-30. PubMed ID: 16538612
[TBL] [Abstract][Full Text] [Related]
13. Genome amplification of chromosome 20 in breast cancer.
Hodgson JG; Chin K; Collins C; Gray JW
Breast Cancer Res Treat; 2003 Apr; 78(3):337-45. PubMed ID: 12755492
[TBL] [Abstract][Full Text] [Related]
14. Dominant genetic alterations in immortalization: role for 20q gain.
Cuthill S; Agarwal P; Sarkar S; Savelieva E; Reznikoff CA
Genes Chromosomes Cancer; 1999 Dec; 26(4):304-11. PubMed ID: 10534765
[TBL] [Abstract][Full Text] [Related]
15. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
Watanabe T; Imoto I; Katahira T; Hirasawa A; Ishiwata I; Emi M; Takayama M; Sato A; Inazawa J
Jpn J Cancer Res; 2002 Oct; 93(10):1114-22. PubMed ID: 12417041
[TBL] [Abstract][Full Text] [Related]
16. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
18. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
Wang D; Zhu ZZ; Jiang H; Zhu J; Cong WM; Wen BJ; He SQ; Liu SF
Hepatol Int; 2015 Jul; 9(3):438-46. PubMed ID: 26067772
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
20. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.
Weiss MM; Snijders AM; Kuipers EJ; Ylstra B; Pinkel D; Meuwissen SG; van Diest PJ; Albertson DG; Meijer GA
J Pathol; 2003 Jul; 200(3):320-6. PubMed ID: 12845628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
